/SINT
SINT Stock - Sintx Technologies, Inc.
Healthcare|Medical - DevicesNASDAQ
$3.61+2.56%
+$0.09 (+2.56%) • Dec 19
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.64
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.95
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $3.97
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SINT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.57 – $3.65
TARGET (TP)$4.15
STOP LOSS$3.32
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.63
52W High$7.36
52W Low$1.71
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.25M | $2.63M | $601,000 | $606,000 | $594,000 |
| Gross Profit | $435,000 | $1.84M | $336,000 | $157,000 | $119,000 |
| Gross Margin | 34.9% | 70.2% | 55.9% | 25.9% | 20.0% |
| Operating Income | $-14,047,000 | $-13,358,000 | $-11,335,000 | $-10,620,000 | $-8,504,000 |
| Net Income | $-11,024,000 | $-8,259,000 | $-12,039,000 | $-9,309,000 | $-7,029,000 |
| Net Margin | -884.8% | -314.4% | -2003.2% | -1536.1% | -1183.3% |
| EPS | $-14.87 | $-35.43 | $-54.67 | $-47.59 | $-44.57 |
Company Overview
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SINTBeat Rate
31%
Last 16 quarters
Avg Surprise
-6463.8%
EPS vs Estimate
Beats / Misses
5/11
Last 12 quarters
Latest EPS
$-3.46
Q4 2025
EPS Surprise History
Q1 24
-2300.0%
$-18.00vs$-0.75
Q2 24
-31328.6%
$-22.00vs$-0.07
Q3 24
+99.6%
$-3.61vs$-996.20
Q4 24
-11.4%
$-6.95vs$-6.24
Q1 25
+37.4%
$-1.14vs$-1.82
Q2 25
-72.0%
$-1.29vs$-0.75
Q3 25
-15.2%
$-0.91vs$-0.79
Q4 25
-529.1%
$-3.46vs$-0.55
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2026 | Nov 9, 2026 | — | — | — | — |
Q3 2026 | Aug 3, 2026 | — | — | — | — |
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Mar 18, 2026 | $-0.51 | — | — | — |
Q4 2025 | Nov 12, 2025 | $-0.55 | $-3.46 | -529.1% | ✗ MISS |
Q3 2025 | Aug 14, 2025 | $-0.79 | $-0.91 | -15.2% | ✗ MISS |
Q2 2025 | May 15, 2025 | $-0.75 | $-1.29 | -72.0% | ✗ MISS |
Q1 2025 | Mar 19, 2025 | $-1.82 | $-1.14 | +37.4% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $-6.24 | $-6.95 | -11.4% | ✗ MISS |
Q3 2024 | Aug 13, 2024 | $-996.20 | $-3.61 | +99.6% | ✓ BEAT |
Q2 2024 | May 13, 2024 | $-0.07 | $-22.00 | -31328.6% | ✗ MISS |
Q1 2024 | Mar 27, 2024 | $-0.75 | $-18.00 | -2300.0% | ✗ MISS |
Q4 2023 | Nov 14, 2023 | $-0.76 | $-162.00 | -21215.8% | ✗ MISS |
Q3 2023 | Aug 8, 2023 | $-0.79 | $-156.00 | -19646.8% | ✗ MISS |
Q2 2023 | May 15, 2023 | $-1.24 | $-348.00 | -27964.5% | ✗ MISS |
Q1 2023 | Mar 29, 2023 | $-5.51 | $-34.69 | -529.6% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-11.50 | $-11.00 | +4.3% | ✓ BEAT |
Q3 2022 | Aug 12, 2022 | $-12.00 | $-10.00 | +16.7% | ✓ BEAT |
Q2 2022 | May 13, 2022 | $-11.50 | $-12.00 | -4.3% | ✗ MISS |
Q1 2022 | Mar 25, 2022 | $-11.50 | $-7.00 | +39.1% | ✓ BEAT |
Latest News
Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $16
➖ NeutralBenzinga•Dec 8, 2025, 10:31 AM
SINTX Technologies Strikes Supply Agreement With Evonik To Produce Proprietary Silicon Nitride-PEEK Compound
📈 PositiveBenzinga•Dec 1, 2025, 01:33 PM
SINTX Technologies Q3 EPS $(1.19) Misses $(0.51) Estimate, Sales $208.000K Miss $300.000K Estimate
📉 NegativeBenzinga•Nov 13, 2025, 01:14 PM
SINTX Technologies Receives FDA 510(K) Clearance For Its SINAPTIC Foot & Ankle Osteotomy Wedge System
📈 PositiveBenzinga•Nov 13, 2025, 01:08 PM
SINTX Technologies Launches OsseoSculpt
📈 PositiveBenzinga•Nov 3, 2025, 01:05 PM
SINTX Technologies Announces FDA 510(K) Clearance For SINAPTIC Foot & Ankle Osteotomy Wedge System; SINTX Plans U.S. Commercial Launch In Q1 2026
📈 PositiveBenzinga•Oct 20, 2025, 11:04 AM
SINTX Technologies Secures Patent for Antipathogenic Fabric Methods, Strengthening Infection-Resistant IP
📈 PositiveBenzinga•Oct 16, 2025, 11:05 AM
SINTX Technologies Expands Patent Protections for Antipathogenic Fabrics, Strengthening Biomedical IP Portfolio
📈 PositiveBenzinga•Oct 14, 2025, 11:16 AM
SiNtx Technologies Enters ATM Agreement With H.C. Wainwright; Prospectus Supplement Filed For $6.4M Shares Of Common Stock
➖ NeutralBenzinga•Oct 3, 2025, 09:13 PM
Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $25
➖ NeutralBenzinga•Sep 22, 2025, 09:43 AM
SINTX Technologies shares are trading lower. The United States Patent and Trademark Office issued a Notice of Allowance for the company's patent application titled, "Antipathogenic Fibrous Materials.
📉 NegativeBenzinga•Sep 8, 2025, 12:56 PM
SINTX Raises $3.8M Through Warrant Exercise to Strengthen Working Capital
📈 PositiveBenzinga•Sep 8, 2025, 11:56 AM
SINTX Technologies Advances Intellectual Property Portfolio With USPTO Patent Allowance For Silicon Nitride Antipathogen Innovation In Medical Devices And PPE
📈 PositiveBenzinga•Sep 8, 2025, 11:05 AM
SiNtx Technologies Appoints Kevin Trask As CFO
➖ NeutralBenzinga•Sep 5, 2025, 08:23 PM
SiNtx Technologies Has Received A Notice Of Allowance For A US Patent Titled "ANTIPATHOGENIC FIBROUS MATERIALS (USED ON AN ANTIVIRAL FACE MASK FOR INACTIVATING AND/OR PREVENTING THE TRANSMISSIN OF A VIRUS)"
📈 PositiveBenzinga•Sep 5, 2025, 05:29 PM
SINTX Technologies shares are trading higher after the company announced publication of a study showing silicon nitride demonstrated antiviral activity against multiple virus strains including SARS-CoV-2 and MERS-CoV.
📈 PositiveBenzinga•Sep 3, 2025, 11:26 AM
SINTX Technologies Announces Publication Of Study Demonstrating That Silicon Nitride Shows Antiviral Activity Against Multiple Virus Strains Including SARS-CoV-2 And MERS-CoV
📈 PositiveBenzinga•Sep 3, 2025, 11:13 AM
SINTX Technologies stock jumps on deal to acquire SiNAPTIC surgical assets
📈 PositiveSeeking Alpha•Jun 24, 2025, 12:52 PM
Frequently Asked Questions about SINT
What is SINT's current stock price?
Sintx Technologies, Inc. (SINT) is currently trading at $3.61 per share. The stock has moved +2.56% today.
What is the analyst price target for SINT?
No analyst price targets are currently available for this stock.
What sector is Sintx Technologies, Inc. in?
Sintx Technologies, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is SINT's market cap?
Sintx Technologies, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does SINT pay dividends?
No, Sintx Technologies, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorDHAI
DIH Holding US, Inc.
$0.00
Mkt Cap: $0.0B
HSCS
HeartSciences Inc.
$2.36
Mkt Cap: $0.0B
IINN
Inspira Technologies Oxy B.H.N. Ltd.
$1.02
Mkt Cap: $0.0B
LFWD
Lifeward Ltd.
$0.65
Mkt Cap: $0.0B
PFSA
Profusa, Inc. Common Stock
$0.12
Mkt Cap: $0.0B
PTHL
Pheton Holdings Ltd Class A Ordinary Shares
$0.50
Mkt Cap: $0.0B
RNAZ
TransCode Therapeutics, Inc.
$7.92
Mkt Cap: $0.0B
SSKN
STRATA Skin Sciences, Inc.
$1.19
Mkt Cap: $0.0B
TNON
Tenon Medical, Inc.
$1.10
Mkt Cap: $0.0B
XAIR
Beyond Air, Inc.
$0.91
Mkt Cap: $0.0B
Explore stocks similar to SINT for comparison